Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.
Zuffa E, Franchini E, Papayannidis C, Baldazzi C, Simonetti G, Testoni N, Abbenante MC, Paolini S, Sartor C, Parisi S, Marconi G, Cattina F, Bochicchio MT, Venturi C, Ottaviani E, Cavo M, Martinelli G.
Zuffa E, et al. Among authors: testoni n.
Oncotarget. 2015 Oct 13;6(31):31284-94. doi: 10.18632/oncotarget.5161.
Oncotarget. 2015.
PMID: 26384303
Free PMC article.